CLINICAL_TRIALS
trial_result
· 2011-03-22
Clinical Trial Update: Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia [Phase 2]
Summary
A Phase 2 trial update on telavancin for uncomplicated Staphylococcus aureus bacteremia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cumberland Pharmaceuticals | Conditions: Gram-Positive Bacterial Infections | Phase 2 | Status: COMPLETED | Results posted: 2011-03-22